Time is getting short for Resverlogix. The scenario floated by the flim-flam man at the Zenith agm may be the last resort. Zenith Epigenetics sells Zen-3694 to fund BOM2 retaining a royalty stream on both Zen-3694 and RVX - it keeps the game going.  

The absence of any concrete information from management is disturbing and telling. No information means no information. We linger in a void until the next mandated dissemination of forward looking statements. Meanwhile the holidays are here again.

Merry Christmas to all and best wishes for a prosperous and Happy New Year!

Chicagoest